Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 1998, p. 2356-2358, Vol. 36, No. 8
Departments of Pathology and Laboratory
Medicine1 and
Medicine,2 Ottawa General Hospital,
University of Ottawa, Ottawa, Ontario, Canada
Received 1 December 1997/Returned for modification 16 March
1998/Accepted 28 April 1998
We determined the frequency of PCR inhibition in genital and urine
specimens submitted for Chlamydia trachomatis testing using the internal control DNA provided with the COBAS AMPLICOR C. trachomatis test and assessed methods to remove it. Inhibition
occurred in 65 of 906 (7%) cervical swabs, 23 of 51 (45%) urethral
swabs, and 2 of 175 (1.1%) urine samples. Overall, inhibition was
eliminated in processed specimens after storage at 4°C in 77 of 90 specimens (86%), freezing at
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Inhibition of PCR in Genital and Urine Specimens
Submitted for Chlamydia trachomatis Testing
70°C in 59 of 82 specimens (72%),
storage at 4°C followed by either 1:100 dilution in 37 of 43 specimens (86%) or 1:10 dilution in 42 of 47 specimens (89%), and
phenol-chloroform extraction in 79 of 80 specimens (99%). No positive
specimens were missed due to inhibition. We conclude that PCR
inhibition is rare with urine specimens and infrequent with
endocervical swabs but occurs frequently with urethral swabs. The
frequency of PCR inhibition may be significantly reduced by methods
which can be easily incorporated into the processing of specimens.
*
Corresponding author. Mailing address: Division of
Microbiology, Ottawa General Hospital, 501 Smyth Rd., Ottawa, Ontario, Canada K1H 8L6. Phone: (613) 737-8323. Fax: (613) 737-8315. E-mail: btoye{at}ogh.on.ca.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|